| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/23/1999 | CA2323095A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | CA2323083A1 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | CA2323078A1 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 09/23/1999 | CA2322795A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2322764A1 Therapeutic chemokine receptor antagonists |
| 09/23/1999 | CA2322699A1 Compositions and methods for enhanced antigen delivery to antigen presenting cells in vivo |
| 09/23/1999 | CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 09/23/1999 | CA2322018A1 Use of vip analogues for preventing and treating brain damage in human babies |
| 09/23/1999 | CA2321113A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | CA2289621A1 Piperazines as inhibitors of fructose-1,6-bisphosphatase (fbpase) |
| 09/23/1999 | CA2288881A1 Therapeutic agent for preventing and/or treating sepsis |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943683A1 Human vanilloid receptor homologue Vanilrep1 |
| 09/22/1999 | EP0943680A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/22/1999 | EP0943679A1 Novel RNase-like protein and its use |
| 09/22/1999 | EP0943624A1 Peptidic inhibitors of down-regulation of growth hormone receptor |
| 09/22/1999 | EP0943623A1 Cyclic hexapeptide antifungal agents |
| 09/22/1999 | EP0943621A2 Process for the production of alkoxycarbonylpeptides intermediates in the synthesis of the lisinopril |
| 09/22/1999 | EP0943339A2 Method of preventing allograft rejection |
| 09/22/1999 | EP0943338A1 Treatment of pulmonary disease |
| 09/22/1999 | EP0943337A2 Use of at least one hydrolytic enzyme and at least one flavonoid for treatment of diseases caused by Hepatitis C viruses |
| 09/22/1999 | EP0943336A1 Peptide-containing pharmaceutical compositions for oral administration |
| 09/22/1999 | EP0943323A1 Cosmetic or dermatological composition containing at least a natural or recombinant arachnida silk protein or an analogue |
| 09/22/1999 | EP0943096A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 09/22/1999 | EP0943004A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 09/22/1999 | EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 09/22/1999 | EP0942998A1 Notch |
| 09/22/1999 | EP0942997A1 Chimeric ltb vaccines |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942987A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 09/22/1999 | EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/22/1999 | EP0942983A2 $i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES |
| 09/22/1999 | EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/22/1999 | EP0942981A1 Fibroblast growth factor-13 |
| 09/22/1999 | EP0942980A1 Tumor-associated kazal inhibitor with pec-60 homology |
| 09/22/1999 | EP0942979A2 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 09/22/1999 | EP0942977A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 09/22/1999 | EP0942976A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 09/22/1999 | EP0942975A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942973A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 09/22/1999 | EP0942972A2 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF |
| 09/22/1999 | EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 09/22/1999 | EP0942960A1 Promotion of regeneration of organized tissues |
| 09/22/1999 | EP0942959A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 09/22/1999 | EP0942935A1 A process for purifying apolipoproteins and a composition for use in the process |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942932A1 Multimeric erythropoietin with increased biological activity |
| 09/22/1999 | EP0942931A2 Modulation of interactions between myosin and integrins |
| 09/22/1999 | EP0942926A2 DISRUPTION OF THE MAMMALIAN Rad51 PROTEIN AND DISRUPTION OF PROTEINS THAT ASSOCIATE WITH MAMMALIAN Rad51 FOR HINDERING CELL PROLIFERATION |
| 09/22/1999 | EP0942925A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 09/22/1999 | EP0942924A2 METHODS AND COMPOUNDS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 09/22/1999 | EP0942923A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 09/22/1999 | EP0942901A1 Cyclic imines as pesticides |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942758A2 Compounds with improved inductive effect on cartilage and bones |
| 09/22/1999 | EP0942755A2 Treatment of diabetes with transcription factor gene |
| 09/22/1999 | EP0942754A2 Conjugates useful in the treatment of prostate cancer |
| 09/22/1999 | EP0942750A1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 09/22/1999 | EP0942749A2 Treatment of stress-induced skin disease by corticotropin releasing hormone antagonists and skin mast cell degranulation inhibitors |
| 09/22/1999 | EP0942746A1 Inhibition of invasive remodelling |
| 09/22/1999 | EP0942745A1 Use of hyaluronidase |
| 09/22/1999 | EP0942744A1 Treatment of bone fracture |
| 09/22/1999 | EP0942743A1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 09/22/1999 | EP0942742A1 Therapeutic compositions for treatment of cancer |
| 09/22/1999 | EP0942741A1 Lectin compositions and uses thereof |
| 09/22/1999 | EP0942740A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 09/22/1999 | EP0942721A1 Pharmaceutical composition |
| 09/22/1999 | EP0804223B1 Hgh containing pharmaceutical compositions |
| 09/22/1999 | EP0771324B1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 09/22/1999 | EP0756449A4 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | EP0615522B1 Muramyl compounds for treatment of septic shock |
| 09/22/1999 | EP0609345B1 Biocompatible implant for the timing of ovulation in mares |
| 09/22/1999 | EP0449948B1 Grafting genetically modified cells to treat diseases of the central nervous system |
| 09/22/1999 | CN1229439A Fusion polypeptides comprising an IgE-binding domain and a HSA component, and their diagnostic and therapeutic uses |
| 09/22/1999 | CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/22/1999 | CN1229414A Multivalent compounds for cross-linking receptors and uses thereof |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229359A Dendritic cell stimulatory factor |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1229133A Insulin kind growth faltor-1 engineering bacteria structure and method for preparation of eka-insulin growth factor-1 |
| 09/22/1999 | CN1228995A Medicine for treating senils dementia, parkinsonism and cardio-cerebral angiopathy |
| 09/22/1999 | CN1228994A Pharmaceutical composition of hedgehog proteins and use thereof |
| 09/22/1999 | CN1228962A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/21/1999 | US5955647 Method for using tobacco mosaic virus to overproduce peptides and proteins |
| 09/21/1999 | US5955624 Angiogenic isolated alk-1-enyl glycerol derivative |
| 09/21/1999 | US5955594 Nucleic acids encoding proteins for early liver development |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955592 Nucleotide and amino acid sequences; for diagnosis of susceptiblity to cancer or diabetes |
| 09/21/1999 | US5955589 Gapped 2' modified oligonucleotides |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955584 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 09/21/1999 | US5955581 Method for producing a stable polymerized hemoglobin blood-substitute |
| 09/21/1999 | US5955579 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression, HOXB13 |
| 09/21/1999 | US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration |
| 09/21/1999 | US5955577 Method for synthesizing a water-soluble β-sheet forming peptide |
| 09/21/1999 | US5955576 Peptide aldehyde analogs that inhibit thrombin or factor xa; for prevention or treatment of abnormal thrombosis |
| 09/21/1999 | US5955575 Antagonists of G-protein-coupled receptor |